6505--Latanoprost Ophthalmic Solution (VA-27-00006027)
VETERANS AFFAIRS, DEPARTMENT OF.VETERANS AFFAIRS, DEPARTMENT OF.NAC PHARMACEUTICALS (36E797) · Response deadline: Tue, 17 Nov 2026
What the government is buying
The Department of Veterans Affairs is soliciting bids for Latanoprost Ophthalmic Solution, a prescription medication used to treat glaucoma and ocular hypertension by reducing intraocular pressure. This procurement falls under Federal Supply Classification 6505, which covers drugs and biologicals. The VA's National Acquisition Center (NAC) Pharmaceuticals program manages this acquisition, consistent with the agency's mission to provide pharmaceutical care to veterans through its integrated health care system.
Key facts
| Attribute | Value |
|---|---|
| Agency | Department of Veterans Affairs, NAC Pharmaceuticals (36E797) |
| Notice type | Solicitation |
| Solicitation number | 36E79727R0039 |
| NAICS | 325412 (Pharmaceutical Preparation Manufacturing) |
| Set-aside | None (full and open competition) |
| Response deadline | November 17, 2026, 2:30 PM CT |
| Place of performance | Not specified in metadata; see the solicitation |
Who can bid
This is a full and open competition with no set-aside program designated, meaning any responsible offeror—regardless of business size—may submit a bid. That said, the NAICS code 325412 (Pharmaceutical Preparation Manufacturing) has a Small Business Administration size standard that may classify some manufacturers as small businesses; see the solicitation for specific size status implications if applicable.
Offerors must generally be registered in SAM.gov, have an active Unique Entity Identifier (UEI), and possess any required federal pharmaceutical manufacturing or distribution registrations. For Schedule-based or open market pharmaceutical procurements, vendors typically need relevant FDA registrations and must comply with VA-specific pharmaceutical procurement requirements, including those related to the VA Federal Supply Schedule or National Contracts program.
How to put together a competitive bid
Pharmaceutical bids to the VA require particular attention to technical, past performance, and pricing factors:
FDA compliance and drug pedigree: Ensure your Latanoprost Ophthalmic Solution has appropriate FDA approval (likely ANDA for generic or NDA for branded product) and that you can document supply chain integrity. The VA typically requires National Drug Code (NDC) verification.
VA pricing precedent: Research historical pricing through tools like VA Contract Awards or FSS pricing databases. The VA's pharmaceutical program is highly price-sensitive; understanding prevailing market rates for this specific strength and package size is essential.
Supply assurance: Demonstrate manufacturing capacity and contingency sourcing. The VA evaluates reliability of supply heavily, particularly for chronic medications like glaucoma therapies that veterans depend on for ongoing care.
Small business subcontracting: As a full and open competition, large businesses should prepare a subcontracting plan if thresholds apply; small businesses should highlight any manufacturer relationships or teaming arrangements that strengthen their offer.
Packaging and labeling: Confirm your product meets VA-specific requirements for unit-of-use packaging, barcoding (likely ISBT 128 or HIBCC), and shelf-life minimums.
Next steps
Read the full solicitation on SAM.gov using solicitation number 36E79727R0039. The response deadline is November 17, 2026, at 2:30 PM Central Time. Verify whether this is a VA Federal Supply Schedule call or an open market requirement, as submission procedures differ significantly. Confirm place of performance, delivery schedule, exact quantities, and all evaluation factors directly in the solicitation document.
View the official notice on SAM.gov →